JP2024518665A5 - - Google Patents

Info

Publication number
JP2024518665A5
JP2024518665A5 JP2024515284A JP2024515284A JP2024518665A5 JP 2024518665 A5 JP2024518665 A5 JP 2024518665A5 JP 2024515284 A JP2024515284 A JP 2024515284A JP 2024515284 A JP2024515284 A JP 2024515284A JP 2024518665 A5 JP2024518665 A5 JP 2024518665A5
Authority
JP
Japan
Prior art keywords
vector
nucleic acid
acid molecule
individual
isolated nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515284A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518665A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/029213 external-priority patent/WO2022241228A2/en
Publication of JP2024518665A publication Critical patent/JP2024518665A/ja
Publication of JP2024518665A5 publication Critical patent/JP2024518665A5/ja
Pending legal-status Critical Current

Links

JP2024515284A 2021-05-14 2022-05-13 加齢に伴う疾患を防止および/または処置することにおける使用のためのsirt6のバリアント Pending JP2024518665A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163188573P 2021-05-14 2021-05-14
US63/188,573 2021-05-14
PCT/US2022/029213 WO2022241228A2 (en) 2021-05-14 2022-05-13 Variants of sirt6 for use in preventing and/or treating age-related diseases

Publications (2)

Publication Number Publication Date
JP2024518665A JP2024518665A (ja) 2024-05-01
JP2024518665A5 true JP2024518665A5 (cg-RX-API-DMAC7.html) 2025-05-20

Family

ID=84029856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515284A Pending JP2024518665A (ja) 2021-05-14 2022-05-13 加齢に伴う疾患を防止および/または処置することにおける使用のためのsirt6のバリアント

Country Status (5)

Country Link
US (1) US20240277868A1 (cg-RX-API-DMAC7.html)
EP (1) EP4338267A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024518665A (cg-RX-API-DMAC7.html)
CA (1) CA3218849A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022241228A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014115022A1 (en) 2013-01-25 2014-07-31 Baylor College Of Medicine A helper-dependent adenoviral gene therapy delivery and expression system
WO2024121363A1 (en) * 2022-12-08 2024-06-13 Genflow Biosciences Srl Variants of sirtuin 6 for the treatment of non-alcoholic fatty liver disease
JP2026507559A (ja) * 2023-02-14 2026-03-04 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク Crisprトランスポゾンシステム及び構成要素
WO2026062177A1 (en) 2024-09-20 2026-03-26 Genflow Biosciences Srl Variants of sirtuin 6 for the treatment of muscular diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2285977A1 (en) * 2008-05-15 2011-02-23 Sirtris Pharmaceuticals, Inc. Sirt1 polymorphic variants and methods of use thereof
JP2015193582A (ja) * 2014-03-28 2015-11-05 国立大学法人 東京大学 イミダゾールジペプチドを含む剤
US20190203207A1 (en) * 2016-05-20 2019-07-04 The Trustees Of Columbia University In The City Of New York Anabolic Enhancers for Ameliorating Neurodegeneration
RU2019121801A (ru) * 2016-12-14 2021-01-15 Лигандал, Инк. Композиции и способы для доставки полезной нагрузки в виде нуклеиновой кислоты и/или белка

Similar Documents

Publication Publication Date Title
JP2021520198A5 (cg-RX-API-DMAC7.html)
JP2023109992A5 (cg-RX-API-DMAC7.html)
JP2023544141A (ja) AIMP2-DX2および必要に応じてmiR-142の標的配列ならびにその組成物を使用した神経系疾患を処置する方法
JP2025120285A5 (cg-RX-API-DMAC7.html)
US20200325454A1 (en) VECTORS CONTAINING AIMP2-DX2 AND TARGET NUCLEIC ACIDS FOR miR 142 AND USES THEREOF
CN106039287B (zh) 热休克蛋白gp96在治疗类风湿性关节炎中的应用
TWI893130B (zh) 編碼smn1蛋白的密碼子優化核酸及其用途
CA2859920A1 (en) Variants of yeast ndi1 gene, and uses thereof in the treatment of disease associated with mitochondrial dysfunction
JP2022543446A (ja) Apoe4 rna特異的トランススプライシングリボザイム及びその用途
JP2023513004A5 (cg-RX-API-DMAC7.html)
JP2017512822A (ja) 新規用途のためのガラクトシド阻害物質
JP2023529371A (ja) シヌクレイノパチーの処置のための組成物および方法
JP2023539368A5 (cg-RX-API-DMAC7.html)
WO2021228052A1 (zh) 生物大分子靶向特异性补体抑制剂及其制备方法与应用
WO2019146745A1 (ja) テイ-サックス病及びザンドホッフ病治療用の新規アデノ随伴ウイルスビリオン
JP2021529519A5 (cg-RX-API-DMAC7.html)
JP2024514193A (ja) ウイルス系の遺伝子治療のためのプロモータ
KR20240128579A (ko) Cd38 또는 이의 단편을 포함하는 자가면역질환 치료용 조성물
JP2023539367A5 (cg-RX-API-DMAC7.html)
JP2023505271A5 (cg-RX-API-DMAC7.html)
JP2022534733A5 (cg-RX-API-DMAC7.html)
KR102626543B1 (ko) AIMP2-DX2 및 miR-142의 표적 핵산을 포함하는 재조합 벡터
JP2021513871A5 (cg-RX-API-DMAC7.html)
JP2025516639A (ja) AIMP2-DX2および必要に応じてmiR-142に対する標的配列を使用して網膜変性疾患を処置する方法ならびにその組成物
US20250092105A1 (en) Granulin/epithelin modules and combinations thereof to treat neurodegenerative disease